Benzodiazepine Discontinuation in Opioid Agonist Therapy
Status:
Completed
Trial end date:
2021-07-08
Target enrollment:
Participant gender:
Summary
The proposed study is a clinical trial, designed to pilot test a Distress
Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist
therapy who currently use benzodiazepines. The DT-BD intervention is an adjunctive
psychosocial intervention in people seeking to discontinue (BZD) use. The goal of the study
is to assess the applicability and feasibility of this intervention through treatment
retention and qualitative interviews with four participants who are receiving opioid agonist
treatment and who regularly use BZDs.